By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dr. Falk Pharma GmbH 

Leinenweberstrasse 5

Freiburg    79108  Germany
Phone: 49-761-15-14-0 Fax: 49-761-15-14-321


Company News
Sigmoid Pharma Announces A Strategic Collaboration With Dr. Falk Pharma GmbH 4/4/2017 12:58:30 PM
Coronado Biosciences Signs Collaboration Agreement With Dr. Falk Pharma GmbH and OvaMed for the Development of TSO for Crohn's Disease 3/22/2012 7:34:47 AM
Lipid Therapeutics Licenses European Rights to its Lead Product, LT-02, to Co-development Partner Dr. Falk Pharma GmbH 3/8/2012 10:40:53 AM
Dong-A PharmTech and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil 6/13/2011 9:23:46 AM
Cosmo Pharmaceuticals S.p.A. Announces Licensing Agreement with Dr. Falk Pharma GmbH for Rifamycin SV MMX(R) 11/24/2008 12:39:00 PM
Sigma-Tau Pharmaceuticals Seeking FDA Approval of Medicine for Rare Genetic Disease Affecting Less Than 100 Americans 7/9/2008 12:37:08 PM
Salix Pharmaceuticals, Ltd. (SLXP) Acquires Budesonide Products from Dr. Falk Pharma GmbH 3/13/2008 9:47:48 AM
Salix Pharmaceuticals, Ltd. (SLXP) Licenses DIACOL(TM) to Dr. Falk Pharma GmbH in Europe 4/17/2007 12:13:05 PM
Altus Pharmaceuticals Inc. And Dr. Falk Pharma GmbH Announce TheraCLEC Granted Orphan Drug Designation By The European Medicines Evaluation Agency10/19/2005 5:11:48 PM